StockNews.AI
CLOV
StockNews.AI
182 days

Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

1. Clover Health will report Q4 and 2024 results on Feb 27, 2025. 2. A conference call is scheduled for discussing financial results. 3. Clover focuses on Medicare while utilizing its Clover Assistant technology. 4. They aim to improve healthcare access for seniors through innovative solutions. 5. Recent data shows Clover's impact on chronic disease management.

4m saved
Insight
Article

FAQ

Why Bullish?

Clover's upcoming earnings call and focus on healthcare access signal growth potential. Positive earnings reports often lead to price gains; similar cases have occurred in the past.

How important is it?

Earnings reports are crucial for investors; they influence valuations significantly. Previous earnings reports caused notable stock price movements.

Why Short Term?

The earnings announcement could lead to immediate market reactions. Historically, strong quarterly results influence stock performance in the short term.

Related Companies

CLOVCMSUNH
February 18, 2025 16:05 ET  | Source: Clover Health Investments, Corp. WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on February 27, 2025, to discuss Clover Health’s fourth quarter and full year 2024 business and financial results. Fourth Quarter and Full Year 2024 Conference Call and Webcast Details: What: Clover Health’s Fourth Quarter and Full Year 2024 Earnings Conference CallWhen: Thursday, February 27, 2025, at 5:00 p.m. Eastern TimeDial In: To access the call via telephone please dial 800-274-8461 (for U.S. callers) or 203-518-9814 (for callers outside the U.S.) and enter the conference ID: CLOVQ424Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months About Clover Health:Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease. Press Contact:Andrew Still-Baxterpress@cloverhealth.com Investor Relations Contact:Ryan Schmidtinvestors@cloverhealth.com

Related News